Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure
Hansoh BioMedical R&D Company
Hansoh BioMedical R&D Company
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Ipsen
Cellectar Biosciences, Inc.
Endeavor Biomedicines, Inc.
Eli Lilly and Company
USWM, LLC (dba US WorldMeds)
Lantheus Medical Imaging
Ricoh USA, Inc.
GlaxoSmithKline
Var2 Pharmaceuticals
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
GlaxoSmithKline
Valo Therapeutics Oy
Tcelltech Inc.
NextPoint Therapeutics, Inc.
MedPacto, Inc.
Emerald Clinical Inc.
Taproot Health
Hansoh BioMedical R&D Company
Hansoh BioMedical R&D Company
Eisai Inc.
Hutchmed
Beijing Immunochina Medical Science & Technology Co., Ltd.
BioEclipse Therapeutics
Cellestia Biotech AG
Power Life Sciences Inc.
Y-mAbs Therapeutics
Shanghai Yunying Medical Technology
Bayer
Base Therapeutics (Shanghai) Co., Ltd.
Y-mAbs Therapeutics
Eisai Inc.
Shanghai Yunying Medical Technology
Innovent Biologics (Suzhou) Co. Ltd.
MacroGenics
AlaMab Therapeutics (Shanghai) Inc.
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Emerald Clinical Inc.
Isofol Medical AB
Celgene
Celgene
Eleison Pharmaceuticals LLC.
Lee's Pharmaceutical Limited
Merck Sharp & Dohme LLC
Insmed Incorporated
Takeda
Novartis
Isofol Medical AB
SillaJen, Inc.